Witnessing the stock’s movement on the chart, on Thursday, Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had a quiet start as it plunged -5.65% to $9.68, before settling in for the price of $10.26 at the close. Taking a more long-term approach, CRBP posted a 52-week range of $4.64-$20.56.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 35.71%. Meanwhile, its Annual Earning per share during the time was 35.71%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -82.37%. This publicly-traded company’s shares outstanding now amounts to $17.55 million, simultaneously with a float of $16.19 million. The organization now has a market capitalization sitting at $169.91 million. At the time of writing, stock’s 50-day Moving Average stood at $13.34, while the 200-day Moving Average is $9.44.
Corbus Pharmaceuticals Holdings Inc (CRBP) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Corbus Pharmaceuticals Holdings Inc’s current insider ownership accounts for 7.79%, in contrast to 49.18% institutional ownership. According to the most recent insider trade that took place on Oct 24 ’25, this organization’s Chief Executive Officer sold 18,660 shares at the rate of 17.01, making the entire transaction reach 317,407 in total value, affecting insider ownership by 138,187. Preceding that transaction, on Oct 27 ’25, Company’s Chief Executive Officer sold 8,973 for 17.14, making the whole transaction’s value amount to 153,797. This particular insider is now the holder of 138,187 in total.
Corbus Pharmaceuticals Holdings Inc (CRBP) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.46 per share during the current fiscal year.
Corbus Pharmaceuticals Holdings Inc’s EPS decrease for this current 12-month fiscal period is -82.37% and is forecasted to reach -4.99 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -13.52% through the next 5 years, which can be compared against the 35.71% growth it accomplished over the previous five years trading on the market.
Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) Trading Performance Indicators
Let’s observe the current performance indicators for Corbus Pharmaceuticals Holdings Inc (CRBP). It’s Quick Ratio in the last reported quarter now stands at 6.31.
In the same vein, CRBP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.51, a figure that is expected to reach -1.54 in the next quarter, and analysts are predicting that it will be -4.99 at the market close of one year from today.
Technical Analysis of Corbus Pharmaceuticals Holdings Inc (CRBP)
Going through the that latest performance of [Corbus Pharmaceuticals Holdings Inc, CRBP]. Its last 5-days volume of 1.23 million indicated improvement to the volume of 0.25 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 11.71% While, its Average True Range was 29.82.
Raw Stochastic average of Corbus Pharmaceuticals Holdings Inc (CRBP) in the period of the previous 100 days is set at 10.75%, which indicates a major rise in contrast to 8.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.75 that was lower than 0.88 volatility it exhibited in the past 100-days period.
